Xiang Fang, Xie Zili, Feng Jing, Yang Weishan, Cao Zhijian, Li Wenxin, Chen Zongyun, Wu Yingliang
State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan 430072, China.
Toxins (Basel). 2015 Jan 5;7(1):34-42. doi: 10.3390/toxins7010034.
The potassium channels were recently found to be inhibited by animal toxin-like human β-defensin 2 (hBD2), the first defensin blocker of potassium channels. Whether there are other defensin blockers from different organisms remains an open question. Here, we reported the potassium channel-blocking plectasin, the first defensin blocker from a fungus. Based on the similar cysteine-stabilized alpha-beta (CSαβ) structure between plectasin and scorpion toxins acting on potassium channels, we found that plectasin could dose-dependently block Kv1.3 channel currents through electrophysiological experiments. Besides Kv1.3 channel, plectasin could less inhibit Kv1.1, Kv1.2, IKCa, SKCa3, hERG and KCNQ channels at the concentration of 1 μΜ. Using mutagenesis and channel activation experiments, we found that outer pore region of Kv1.3 channel was the binding site of plectasin, which is similar to the interacting site of Kv1.3 channel recognized by animal toxin blockers. Together, these findings not only highlight the novel function of plectasin as a potassium channel inhibitor, but also imply that defensins from different organisms functionally evolve to be a novel kind of potassium channel inhibitors.
最近发现钾通道受到动物毒素样的人β-防御素2(hBD2)抑制,hBD2是首个钾通道防御素阻滞剂。不同生物体中是否存在其他防御素阻滞剂仍是一个悬而未决的问题。在此,我们报道了钾通道阻断剂plectasin,它是首个来自真菌的防御素阻滞剂。基于plectasin与作用于钾通道的蝎毒素之间相似的半胱氨酸稳定α-β(CSαβ)结构,我们通过电生理实验发现plectasin可剂量依赖性地阻断Kv1.3通道电流。除Kv1.3通道外,在1μM浓度下,plectasin对Kv1.1、Kv1.2、IKCa、SKCa3、hERG和KCNQ通道的抑制作用较弱。通过诱变和通道激活实验,我们发现Kv1.3通道的外孔区域是plectasin的结合位点,这与动物毒素阻滞剂识别的Kv1.3通道相互作用位点相似。总之,这些发现不仅突出了plectasin作为钾通道抑制剂的新功能,还暗示来自不同生物体的防御素在功能上进化为一种新型钾通道抑制剂。